Wertpapierdatensatz · archiviertes Quartal
SMMT
Summit Therapeutics Inc. · Healthcare · Biotechnology
15Erfasste Halter
-1Δ Inhaber
45.07MGehaltene Aktien
$931.26MGemeldeter Wert
+1Neue Positionen
−3Ausstiege
Momentum-Eingaben (vergleichbare Manager):
Halterbreite -6.2% ·
Aktienfluss +14.3% ·
neue Nettopositionen -13.3%
— Formel
Konzentrierte Akkumulation — steigende Anteile bei weniger Haltern
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q3 2025
Beteiligung im Zeitverlauf
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 86 | +5 | 84.29M | $1.23B | +8 | −2 |
| Q1 2026 | 82 | +1 | 68.40M | $1.29B | +10 | −10 |
| Q4 2025 | 81 | 0 | 72.69M | $1.27B | +1 | — |
| Q3 2025 | 15 | -1 | 45.07M | $931.26M | +1 | −3 |
| Q2 2025 | 14 | 0 | 38.14M | $811.62M | +1 | −1 |
| Q1 2025 | 11 | +1 | 18.29M | $352.78M | +1 | — |
| Q4 2024 | 10 | +1 | 17.85M | $318.58M | +1 | — |
| Q3 2024 | 8 | 0 | 10.94M | $239.67M | +1 | −1 |
| Q2 2024 | 8 | — | 7.47M | $58.27M | — | — |
Wer es hält · Q3 2025
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passiv) | 11.38M | +31.2% | $235.11M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | The Vanguard Group ✦ (passiv) | 11.38M | +31.2% | $235.11M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | The Vanguard Group ✦ (passiv) | 11.38M | +31.2% | $235.11M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | The Vanguard Group ✦ (passiv) | 11.38M | +31.2% | $235.11M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Fidelity (FMR) ✦ | 8.92M | -3.3% | $184.24M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | Fidelity (FMR) ✦ | 8.92M | -3.3% | $184.24M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | Fidelity (FMR) ✦ | 8.92M | -3.3% | $184.24M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | Fidelity (FMR) ✦ | 8.92M | -3.3% | $184.24M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | BlackRock ✦ (passiv) | 7.36M | +7.5% | $152.14M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | BlackRock ✦ (passiv) | 7.36M | +7.5% | $152.14M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | BlackRock ✦ (passiv) | 7.36M | +7.5% | $152.14M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | BlackRock ✦ (passiv) | 7.36M | +7.5% | $152.14M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | BlackRock ✦ (passiv) | 7.36M | +7.5% | $152.14M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | BlackRock ✦ (passiv) | 7.36M | +7.5% | $152.14M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | BlackRock ✦ (passiv) | 7.36M | +7.5% | $152.14M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | BlackRock ✦ (passiv) | 7.36M | +7.5% | $152.14M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | BlackRock ✦ (passiv) | 7.36M | +7.5% | $152.14M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | BlackRock ✦ (passiv) | 7.36M | +7.5% | $152.14M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | BlackRock ✦ (passiv) | 7.36M | +7.5% | $152.14M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 20 | BlackRock ✦ (passiv) | 7.36M | +7.5% | $152.14M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 21 | State Street Global Advisors ✦ (passiv) | 6.36M | +58.4% | $131.44M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 22 | T. Rowe Price ✦ | 4.54M | +16.2% | $93.77M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 23 | T. Rowe Price ✦ | 4.54M | +16.2% | $93.77M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 24 | Geode Capital Management ✦ (passiv) | 3.13M | +6.7% | $64.74M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 25 | Geode Capital Management ✦ (passiv) | 3.13M | +6.7% | $64.74M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 26 | Morgan Stanley ✦ | 1.93M | — | $39.81M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Morgan Stanley ✦ | 1.93M | — | $39.81M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Morgan Stanley ✦ | 1.93M | — | $39.81M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Morgan Stanley ✦ | 1.93M | — | $39.81M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Morgan Stanley ✦ | 1.93M | — | $39.81M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Morgan Stanley ✦ | 1.93M | — | $39.81M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Goldman Sachs Group ✦ | 497.55K | — | $10.28M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | Goldman Sachs Group ✦ | 497.55K | — | $10.28M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | JPMorgan Chase ✦ | 273.25K | — | $5.65M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | JPMorgan Chase ✦ | 273.25K | — | $5.65M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | JPMorgan Chase ✦ | 273.25K | — | $5.65M | 0.0% | n/c | 1 | SEC ↗ |
| 37 | JPMorgan Chase ✦ | 273.25K | — | $5.65M | 0.0% | n/c | 1 | SEC ↗ |
| 38 | JPMorgan Chase ✦ | 273.25K | — | $5.65M | 0.0% | n/c | 1 | SEC ↗ |
| 39 | JPMorgan Chase ✦ | 273.25K | — | $5.65M | 0.0% | n/c | 1 | SEC ↗ |
| 40 | Citadel Advisors ✦ | 202.71K | +97.9% | $4.19M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 41 | Citadel Advisors ✦ | 202.71K | +97.9% | $4.19M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 42 | AQR Capital Management ✦ | 187.48K | +740.3% | $3.87M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 43 | AQR Capital Management ✦ | 187.48K | +740.3% | $3.87M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 44 | AQR Capital Management ✦ | 187.48K | +740.3% | $3.87M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 45 | D. E. Shaw & Co. ✦ | 130.63K | -5.0% | $2.70M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 46 | D. E. Shaw & Co. ✦ | 130.63K | -5.0% | $2.70M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 47 | Millennium Management ✦ | 120.51K | -78.3% | $2.49M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 48 | Two Sigma Investments ✦ | 25.03K | Neu | $517,120 | 0.0% | New | 1 | SEC ↗ |
| 49 | Gotham Asset Management ✦ | 15.73K | 0.0% | $324,920 | 0.0% | ▼ Trim | 6 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Two Sigma Investments | $517,120 | 0.0% |
Ausgestiegen
| Norges Bank | $29.58M | war 0.0% |
| Marshall Wace | $5.78M | war 0.0% |
| Wellington Management | $844,689 | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 223 Inhaber, 118.88M Anteile, $2.10B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Häufig gemeinsam gehalten
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.
Herkunft: Beteiligung aus geparsten 13F-Common-Stock-Positionen (verfolgte Grundgesamtheit, vergleichbare Sets für Veränderungen); Insider-Zeilen aus Formularen 3/4/5; Beteiligungen aus Schedules 13D/13G; jede Einreichung verlinkt auf das Original auf SEC EDGAR.
Berichtszeitraum: Q3 2025 ·
Methodik ·
Über die API abrufen